StockData
Gyre Therapeutics, Inc. logo

Gyre Therapeutics, Inc. (GYRE) stock

GYRENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/3020% below fair value
$4.21−0.31 (-6.86%)

Close on Nov 20, 2026Market cap $469.46MP/E –Yield –

Gyre Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Gyre Therapeutics's market cap was $451.70M on Nov 11, 2026, against $704.40M a year earlier. Over the last 5 years it ranged from $124.60M to $1.39B, with a median of $666.29M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$451.70M-29.6%
2025Dec 31, 2025$641.69M-38.2%
2024Dec 31, 2024$1.04B+6.4%
2023Dec 29, 2023$975.66M+289.7%
2022Dec 30, 2022$250.35M-17.0%
2021Dec 31, 2021$301.64M-85.6%
2020Dec 31, 2020$2.09B+70.1%
2019Dec 31, 2019$1.23B-13.1%
2018Dec 31, 2018$1.41B+60.3%
2017Dec 29, 2017$881.90M+657.8%
2016Dec 30, 2016$116.38M-78.3%
2015Dec 31, 2015$535.78M+428.2%
2014Dec 31, 2014$101.44M-36.4%
2013Dec 31, 2013$159.42M-5.1%
2012Dec 31, 2012$167.99M-20.8%
2011Dec 30, 2011$212.19M-72.6%
2010Dec 31, 2010$775.36M–

More Gyre Therapeutics figures

See a number that looks wrong?